BusinessEntia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic UsesBy Nasdaq OMXNov 2, 2016, 7:20 PM UTC
BusinessImmune Design to Report Third Quarter 2016 Financial Results & Present at Upcoming Investor ConferenceBy Nasdaq OMXNov 2, 2016, 12:01 PM UTC
BusinessImmune Design to Report Third Quarter 2016 Financial Results & Present at Upcoming Investor ConferenceBy Nasdaq OMXNov 2, 2016, 12:01 PM UTC
BusinessKamada Announces Plan for Phase 2/3 Clinical Trial with Alpha-1 Antitrypsin IV for Treatment of Graft-Versus-Host DiseaseBy Nasdaq OMXNov 2, 2016, 11:30 AM UTC
BusinessTonix Pharmaceuticals to Present at 22nd Annual BIO-Europe® International Partnering ConferenceBy Nasdaq OMXNov 2, 2016, 11:00 AM UTC
BusinessApricus Biosciences Announces Corporate Update and Third Quarter 2016 Financial Results Conference CallBy Nasdaq OMXNov 2, 2016, 11:00 AM UTC
BusinessMacroGenics to Participate in Two Upcoming Investor ConferencesBy Nasdaq OMXNov 1, 2016, 9:00 PM UTC
BusinessTonix Pharmaceuticals to Present Clinical Data at the 2016 Neuroscience Education Institute (NEI) Psychopharmacology CongressBy Nasdaq OMXNov 1, 2016, 8:30 PM UTC
